Australia data – October Manufacturing PMI 52.7 (preliminary 52.8, prior 53.5)

Comments from Markit:

• The latest Australian Manufacturing PMI reflected
  continued expansion at the start of the fourth quarter,
  though the rate of growth slowed from September.
  Foreign demand for Australian manufactured goods
  notably saw growth slow to almost a halt in the latest
  survey.
  Positively, suppliers’ delivery times lengthened at
  the slowest rate since before the COVID-19
  Covid-19
  
  Covid-19 or the novel Coronavirus is a pandemic that has yielded wide ranging economic turmoil and volatility across financial markets in 2020.  The first cases of Covid-19 were reported in Wuhan, China in late 2019. Since then, the virus has expanded globally, infecting millions worldwide.  The virus has been extremely controversial, namely in the United States, which became heavily politicized during the 2020 presidential election. The Covid-19 pandemic is completely unprecedented in modern times, with the most recent example being the influenza outbreak in 1918.  Financial markets and global economies were completely unprepared for the scope of the virus, causing massive shutdowns, unemployment, and other hardships in an effort to contain and mitigate the virus. How Has Covid-19 Affected Markets? Virtually every asset has in some way been affected by Covid-19. Early on, financial markets and equities collapsed, with the nadir coming in March 2020 in the United States and Europe. Widespread lockdowns led to an economic standstill, resulting in stimulus packages to help keep domestic economies functioning.  The result of this has been a depreciation of currencies such as the US dollar, with the Federal Reserve printing billions of dollars to pare economic losses. Forex markets have since experienced historic levels of volatility, leading some to classify the Covid-19 pandemic as a Black Swan event. Financial markets have for the most part rebounded in 2020 at the time of writing, though many headwinds remain in terms of economic recovery. Presently, unemployment rates and other indicators remain problematic, and when coupled with rising rates of infection, portend additional monetary policy action or stimulus in both Europe and the US. At the time of writing there is no vaccine for Covid-19 though several companies such as Pfizer and Moderna are close to producing a viable vaccine.
  
  Covid-19 or the novel Coronavirus is a pandemic that has yielded wide ranging economic turmoil and volatility across financial markets in 2020.  The first cases of Covid-19 were reported in Wuhan, China in late 2019. Since then, the virus has expanded globally, infecting millions worldwide.  The virus has been extremely controversial, namely in the United States, which became heavily politicized during the 2020 presidential election. The Covid-19 pandemic is completely unprecedented in modern times, with the most recent example being the influenza outbreak in 1918.  Financial markets and global economies were completely unprepared for the scope of the virus, causing massive shutdowns, unemployment, and other hardships in an effort to contain and mitigate the virus. How Has Covid-19 Affected Markets? Virtually every asset has in some way been affected by Covid-19. Early on, financial markets and equities collapsed, with the nadir coming in March 2020 in the United States and Europe. Widespread lockdowns led to an economic standstill, resulting in stimulus packages to help keep domestic economies functioning.  The result of this has been a depreciation of currencies such as the US dollar, with the Federal Reserve printing billions of dollars to pare economic losses. Forex markets have since experienced historic levels of volatility, leading some to classify the Covid-19 pandemic as a Black Swan event. Financial markets have for the most part rebounded in 2020 at the time of writing, though many headwinds remain in terms of economic recovery. Presently, unemployment rates and other indicators remain problematic, and when coupled with rising rates of infection, portend additional monetary policy action or stimulus in both Europe and the US. At the time of writing there is no vaccine for Covid-19 though several companies such as Pfizer and Moderna are close to producing a viable vaccine.
  Read this Term pandemic
  hit while prices also increased to the weakest degree
  since early 2021. This suggested the easing of these
  manufacturing sector constraints, although there
  remained some reports that purchasing activity
  remained mildly affected by supply issues.
  Business sentiment meanwhile showed signs of a
  turnaround with the uplift in business confidence from
  the September low, which was a positive sign for sector
  growth in the near-term.